Asst. Prof. ANIL ŞAHİN

Publication Network

Articles 37

1. Timing and Adherence Matter for Sodium–Glucose Cotransporter-2 Inhibitors in Heart Failure

YILMAZ M. B., Celik A., ŞAHİN A., Colluoglu T., Ural D., Kanik A., et al.

Journal of the American Heart Association , vol.14, no.7, 2025 (SCI-Expanded, Scopus)

2. Real-Life Individual Comparison of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure and Diabetes Mellitus

YILMAZ M. B., Celik A., Colluoglu T., ŞAHİN A., Ural D., Kanik A., et al.

American Journal of Cardiovascular Drugs , vol.25, no.2, pp.277-286, 2025 (SCI-Expanded, Scopus)

3. In Response to “The Importance of Age Standardisation in Comparing Regional Inequalities”

ŞAHİN A., Çöllüoğlu T., Çelik A., Ata N., YILMAZ M. B., Ural D., et al.

Balkan Medical Journal , vol.42, no.2, pp.181-182, 2025 (SCI-Expanded, Scopus, TRDizin)

4. Impact of implantable cardioverter defibrillators on mortality in heart failure receiving quadruple guideline-directed medical therapy: a propensity score-matched study.

Sahin A., Celik A., Ural D., Colluoglu I. T., Ata N., Kanik E. A., et al.

BMC medicine , vol.22, no.1, pp.539, 2024 (SCI-Expanded, Scopus)

5. Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy

Çöllüoğlu İ. T., Çelik A., Ata N., Ural D., ŞAHİN A., Ulgu M. M., et al.

International Journal of Cardiology , vol.407, 2024 (SCI-Expanded)

6. Outcomes of patients with heart failure in Türkiye.

Şahin A., Yilmaz M. B., Çelik A., Çöllüoğlu İ. T., Ural D., Asarcikli L. D., et al.

Turkish journal of medical sciences , vol.54, no.7, pp.1488-1496, 2024 (SCI-Expanded, Scopus, TRDizin)

7. The Relationship Between Bendopnea and Atrial Fibrillation in Patients with Heart Failure with Reduced Ejection Fraction

ŞAHİN A., ÖZTEKİN G. M. Y., GENÇ A., KAYA H., YILMAZ M. B.

MN Kardiyoloji , vol.31, no.2, pp.60-66, 2024 (Peer-Reviewed Journal)

8. Two-year experience with balloon-expandable transcatheter aortic valve replacement in severe aortic stenosis at a tertiary center

Şahin A., Canpolat A. C., Gül E., Çerik İ. B., Gül İ.

Cumhuriyet Tıp Dergisi (ELEKTRONİK) , vol.46, no.2, pp.129-135, 2024 (Peer-Reviewed Journal)

9. Approaching a nationwide registry: analyzing big data in patients with heart failure.

Çöllüoğlu T., Şahin A., Çelik A., Kanik E. A.

Turkish journal of medical sciences , vol.54, no.7, pp.1455-1460, 2024 (SCI-Expanded, Scopus, TRDizin)

10. Diagnostic approach to heart failure in Türkiye.

Ural D., Asarcikli L. D., Çöllüoğlu İ. T., Şahin A., Çavuşoğlu Y., Yilmaz M. B., et al.

Turkish journal of medical sciences , vol.54, no.7, pp.1461-1469, 2024 (SCI-Expanded)

11. Medical and advanced heart failure therapies in Türkiye.

Nalbantgil S., Demir E., Çelik A., Çöllüoğlu İ. T., Ata N., Yilmaz M. B., et al.

Turkish journal of medical sciences , vol.54, no.7, pp.1470-1477, 2024 (SCI-Expanded)

12. Burden of comorbidities in heart failure patients in Türkiye.

Çavuşoğlu Y., Murat S., Şahin A., Çöllüoğlu İ. T., Ural D., Yilmaz M. B., et al.

Turkish journal of medical sciences , vol.54, no.7, pp.1478-1487, 2024 (SCI-Expanded, Scopus, TRDizin)

13. Epidemiology of heart failure in Türkiye.

Ata N., Çöllüoğlu İ. T., Şahin A., Yilmaz M. B., Nalbantgil S., Birinci Ş., et al.

Turkish journal of medical sciences , vol.54, no.7, pp.1447-1454, 2024 (SCI-Expanded)

14. Navigating Heart Failure: Unveiling Sex Disparities in Guideline-Directed Medical Therapy Combinations

Celik A., ŞAHİN A., Ata N., Colluoglu I. T., Ural D., Kanik E. A., et al.

American Journal of Cardiology , vol.216, pp.27-34, 2024 (SCI-Expanded, Scopus)

15. The Relationship Between Living with Family and Clinical, Demographic, and Laboratory Characteristics in Patients with Heart Failure

Şahin E. T., Yılmaz Öztekin G. M., Genç A., Şahin A.

Cumhuriyet Tıp Dergisi (ELEKTRONİK) , vol.46, no.1, pp.35-40, 2024 (Peer-Reviewed Journal)

16. Mortality predictor in heart failure patients with preserved ejection fraction: pulmonary artery pulsatility index

Koyun E., ŞAHİN A.

Acta Cardiologica , vol.79, no.8, pp.935-941, 2024 (SCI-Expanded)

17. Exploring Regional Disparities in Heart Failure Epidemiology and Outcomes: A Comprehensive Study Across Geographical Regions in Türkiye

ŞAHİN A., Çöllüoğlu T., Çelik A., Ata N., YILMAZ M. B., Ural D., et al.

Balkan Medical Journal , vol.41, no.1, pp.47-53, 2024 (SCI-Expanded, Scopus, TRDizin)

18. Electrocardiographic Prognostic Marker in Pulmonary Arterial Hypertension: RS Time Marcador Prognóstico Eletrocardiográfico na Hipertensão Arterial Pulmonar: Tempo de RS

Koyun E., ŞAHİN A., YILMAZ A., DİNDAŞ F., Cerik I. B., KOYUN G. B.

Arquivos brasileiros de cardiologia , vol.121, no.9, 2024 (SCI-Expanded)

19. Screening Tests Predicting Cancer Metastasis in the Etiology of Pericardial Effusion: HALP Score and PNI

KOYUN E., DİNDAŞ F., ŞAHİN A., Cerik I. B., Dogdus M.

Arquivos Brasileiros de Cardiologia , vol.121, no.1, 2024 (SCI-Expanded)

20. Koroner Arter Hastalığı Varlığında Periferik Arter Hastalığının Prediktörleri: Plazma Aterojenik İndeks ve Trigliserit Glikoz İndeksi.

KOYUN E., ŞAHİN A., DİNDAŞ F., ÇERİK İ. B., KANAL Y., Karabey E.

MN Kardiyoloji , vol.30, no.4, pp.145-149, 2023 (Peer-Reviewed Journal)

21. Why has the incidence of heart failure decreased by half in Türkiye?—Authors’ reply

Çelik A., Çöllüoğlu İ. T., ŞAHİN A., Ural D., YILMAZ M. B., Ata N.

The Lancet Regional Health - Europe , vol.35, 2023 (ESCI)

22. Trends in heart failure between 2016 and 2022 in Türkiye (TRends-HF): a nationwide retrospective cohort study of 85 million individuals across entire population of all ages

Celik A., Ural D., ŞAHİN A., Colluoglu I. T., Kanik E. A., Ata N., et al.

The Lancet Regional Health - Europe , vol.33, 2023 (ESCI, Scopus)

23. Can frontal QRS-T angle predict mortality in patients with severe Crimean-Congo Hemorrhagic Fever?

Şahin A., Gündoğdu O., Avcı O.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , vol.7, no.3, pp.181-186, 2023 (ESCI)

24. Predicting Long-Term Mortality in Acute Pulmonary Embolism: The Role of RDW Levels

KERKÜTLÜOĞLU M., ŞAHİN A., YÜCEL O., GÜNEŞ H., YILMAZ M. B., ZORLU A.

Medical Science and Discovery , vol.10, no.5, pp.319-324, 2023 (Peer-Reviewed Journal)

25. Effects of the perimenopausal period on the course of heart failure

BAN ŞAHİN E. T., Yılmaz Öztekin G. M., Genç A., sahin a., Özen M.

Cukurova Medical Journal , vol.48, no.1, pp.136-144, 2023 (ESCI, TRDizin)

26. Effect of Bendopnea on Achievement Medical Treatment Target Doses in Heart Failure

Öztekin G. M. Y., Genç A., ŞAHİN A., Çağırcı G., Arslan Ş.

Archives of Iranian Medicine , vol.26, no.1, pp.36-42, 2023 (SCI-Expanded)

27. Frequency and predictors of hyperkalemia in the heart failure outpatient clinic

Yılmaz Öztekin G. M., Genç A., Şahin A., Çağırcı G., Arslan Ş.

ACTA MEDICA ALANYA , vol.6, no.3, pp.278-284, 2022 (TRDizin)

28. New prognostic markers in pulmonary arterial hypertension: CRP to albumin ratio and uric acid.

Cerik İ. B., Dindas F., Koyun E., Dereli S., Sahin A., Turgut O. O., et al.

Clinical biochemistry , vol.100, pp.22-28, 2022 (SCI-Expanded, Scopus)

29. Increased frequency of occurrence of bendopnea is associated with poor outcomes in heart failure outpatients

KAYA H., Sahin A., Gunes H., Bekar L., Celik A., ÇAVUŞOĞLU Y., et al.

ACTA CARDIOLOGICA , vol.76, no.8, pp.878-886, 2021 (SCI-Expanded)

30. Atherogenic indexes versus hematologic inflammatory indexes: What is the most useful predictor of coronary slow flow?

DİNDAŞ F., KOYUN E., ÇERİK İ. B., ŞAHİN A., KİLİT C., DOĞDUŞ M.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , vol.12, pp.932-936, 2021 (ESCI)

31. Cancer antigen-125 is a predictor of mortality in patients with pulmonary arterial hypertension

Sahın A., Kaya H., Avcı O.

CLINICAL BIOCHEMISTRY , vol.89, pp.58-62, 2021 (SCI-Expanded)

32. Uric Acid and P-Wave Dispersion in Subjects with Heart Failure

KURT R., ŞAHİN A.

Medical Laboratory Technology Journal , vol.7, 2021 (Peer-Reviewed Journal)

33. Kalp Yetersizliği Olan Hastalarda Natriüretik Peptid Düzeyleri ile Uyku Kalitesi Arasındaki İlişki

KURT R., ŞAHİN A., GÜNEŞ H., TURGUT O. O., TEKİN G., YILMAZ M. B.

MN KARDİYOLOJİ , vol.27, no.4, pp.189-196, 2020 (Peer-Reviewed Journal)

34. Increased Monocyte Count is Related to the Development of Atrial Fibrillation in Subjects with Heart Failure

KURT R., ŞAHİN A.

Medical Laboratory Technology Journal , vol.6, no.2, pp.100-107, 2020 (Peer-Reviewed Journal)

35. Association between stasis dermatitis and length of stay in heart failure hospitalizations

KAYA Ö., ŞAHİN A., KAYA H.

International Journal of the Cardiovascular Academy , vol.6, 2020 (Peer-Reviewed Journal)

36. Relationship between sST2 levels and prognosis in patients with pulmonary arterial hypertension

Sahin A., KAYA H., GÜL İ.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , vol.11, pp.172-177, 2020 (ESCI)

37. Yüksek Parathormon Seviyelerinin Koroner Yavaş Akım Fenomeni İle İlişkisi

KURT R., ŞAHİN A.

MN Kardiyoloji , vol.27, no.3, 2020 (Peer-Reviewed Journal)

Papers Presented at Peer-Reviewed Scientific Conferences 27

1. Trombüs yükü fazla olan hastada perkutan koroner girişim sırasında gerçekleşen katater trombüsü ve yönetim

CANPOLAT A. C., KANAL Y., ŞAHİN A.

40. Ulusal Kardiyoloji Kongresi, Antalya, Turkey, 6 - 10 October 2024, (Summary Text)

2. Kalp Yetersizliği Hastalarında sST-2 Düzeyleri Kötüleşen Kalp Yetersizliğini Ön gördürebilir mi?

Şahin A.

1. Avrasya Kalp Yetersizliği Kongresi, Muğla, Turkey, 10 - 13 October 2024, pp.25, (Summary Text)

3. Unlocking survival: assessment of potassium levels in heart failure with quadruple guideline directed medical therapy across all ejection fraction spectrum

Yılmaz M. B., Çöllüoğlu İ. T., Şahin A., Ural D., Ata N., Çelik A.

ESC Heart Failure Congress 2024, Lisbon, Portugal, 11 - 14 May 2024, pp.121-122, (Summary Text)

4. Navigating heart failure: unveiling sex disparities in guideline-directed medical therapy combinations

Çelik A., Şahin A., Ata N., Çöllüoğlu İ. T., Ural D., Kanık E. A., et al.

ESC Heart Failure Congress 2024, Lisbon, Portugal, 11 - 14 May 2024, pp.123, (Summary Text)

5. How can we increase adherence to medical treatment in heart failure patients? A questionnaire study

Kaya H., Şahin A., Akşit E., Yılmaz M. B.

ESC Heart Failure Congress 2024, Lisbon, Portugal, 11 - 14 May 2024, pp.85-86, (Summary Text)

6. Impact of defibrillators on mortality in patients with quadruple guideline-directed medical therapy: a propensity score-matched study

Şahin A., Çelik A., Ural D., Çöllüoğlu İ. T., Ata N., Kanık E. A., et al.

ESC Heart Failure Congress 2024, Lisbon, Portugal, 11 - 14 May 2024, pp.265, (Summary Text)

7. The relationship between serum sodium variability and survival in heart failure patients: results from TRends-HF

Murat S., Çavuşoğlu Y., Şahin A., Çöllüoğlu İ. T., Çelik A., Yılmaz M. B.

ESC Heart Failure Congress 2024, Lisbon, Portugal, 11 - 14 May 2024, pp.337

8. Hyponatremia is highly prevalent and associated with worse clinical outcomes in HF population in Turkiye: results from TRends-HF

Murat S., Çavuşoğlu Y., Şahin A., Çöllüoğlu İ. T., Çelik A., Yılmaz M. B.

ESC Heart Failure Congress 2024, Lisbon, Portugal, 11 - 14 May 2024, pp.142, (Summary Text)

9. Deciphering mortality risk of antidiabetic medications in well-treated heart failure patients with diabetes mellitus

Çöllüoğlu İ. T., Çelik A., Ata N., Ural D., Şahin A., Ülgü M. M., et al.

ESC Heart Failure Congress 2024, Lisbon, Portugal, 11 - 14 May 2024, pp.328-329, (Summary Text)

10. Survival analysis in heart failure and end-stage chronic kidney disease: a propensity score matched study comparing peritoneal dialysis and hemodialysis

Ata N., Çöllüoğlu İ. T., Çelik A., Şahin A., Ayvalı M. O., Kanık E. A., et al.

ESC Heart Failure Congress 2024, Lisbon, Portugal, 11 - 14 May 2024, pp.330, (Summary Text)

11. Kötüleşen Kalp Yetersizliği Nedeniyle Hastaneye Yatan Hastalarda Ekokardiyografik Killip Skorunun Hastane İçi Mortaliteyi Öngördürmede Rolü

Şahin A.

TKD Ulsual Kalp Yetersizliği Toplantısı 2024, İstanbul, Turkey, 24 May 2024, pp.44, (Summary Text)

12. Is bendopnea associated with atrial fibrillation in heart failure patients with reduced ejection fraction?

Şahin A., Yılmaz Öztekin G. M., Genç A., Kaya H., Yılmaz M. B.

ESC Heart Failure Congress 2023, Praha, Czech Republic, 20 - 23 May 2023, pp.245, (Summary Text)

13. Kombine şiddetli mitral ve triküspit kapak yetersizliği bulunan kalp yetersizliği hastalarında cinsiyete göre farklılıklar

Şahin A., Koyun E.

2. Ulusal Kalp Yetersizliği Toplantısı, İstanbul, Turkey, 02 June 2023, pp.4, (Summary Text)

14. Kalp yetersizliği hastalarında aileyle birlikte yaşamanın hastalığı klinik, demografik ve laboratuvar özellikleriyle ilişkisi

Şahin E. T., Yılmaz Öztekin G. M., Genç A., Şahin A.

2. Ulusal Kalp Yetersizliği Toplantısı, İstanbul, Turkey, 02 June 2023, pp.4, (Summary Text)

15. PERIPHERAL ARTERY DISEASE PREDICTORS IN THE PRESENCE OF CORONARY ARTERY DİSEASE:ATHEROGENIC INDEX OF PLASMA AND TRIGLYCERIDE GLUCOSE INDEX

KOYUN E., ŞAHİN A., ÇERİK İ. B., DİNDAŞ F., KARABEY E., KARABEY E.

Advanced Stroke and Peripheral Intervention Course (ASPIC 2023), 4 - 06 May 2023, (Full Text)

16. PULMONER ARTERIYEL HIPERTANSIYONDA PERIFERIK VENOARTERIYEL KARBONDIOKSIT BASINÇ FARKININ KLINIK DURUM ILE İLIŞKISI

ŞAHİN A., ÇERİK İ. B.

PAH Akademi Pulmoner Vasküler Hastalıklar Kongresi, İzmir, Turkey, 09 June 2022, (Summary Text)

17. THE ROLE AND IMPORTANCE OF PERICARDIAL EFFUSIONS IN THE DIAGNOSIS OF MALIGNANCY

Koç T., Ünlüer N. B., Şahin A., Tuncer E.

III. International Cancer Days, Sivas, Turkey, 15 September 2022, pp.300, (Summary Text)

18. CAN SYSTEMIC INFLAMMATORY INDEX PREDICT THE PRESENCE OF CANCER IN PATIENTS WITH PERICARDIAL EFFUSION?

Şahin A., Koyun E., Dindaş F., Çerik İ. B.

III. International Cancer Days, Sivas, Turkey, 15 September 2022, pp.148-153, (Full Text)

19. Peripartum kardiyomiyopati olgusunun uzun dönem takibi ve karşılaşılan zorluklar

Şahin A.

1. Ulusal Kalp Yetersizliği Toplantısı, İstanbul, Turkey, 27 May 2022, pp.8-9, (Summary Text)

20. Serum Elabela level is associated with left atrial function in non-cardioembolic stroke patients

DİNDAŞ F., ŞAHİN A.

37th Turkish Cardiology Congress with International Participation, Turkey, 18 - 21 November 2021, (Full Text)

21. Pulmonary and Cerebral Embolism Caused by Thrombus Entrapped in Patent Foramen Ovale

YILMAZ ÖZTEKİN G. M., ŞAHİN A., GENÇ A., ARSLAN Ş.

37. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, Turkey, 18 - 21 November 2021

22. Atherogenic Indexes Versus Hematologic Inflammatory Indexes: What is Most Useful Predictor of Coronary Slow Flow?

DİNDAŞ F., KOYUN E., ÇERİK İ. B., ŞAHİN A., KİLİT C., DOĞDUŞ M.

Cardiovascular Academy Congress and International Young Academy of Cardiology E-Congress, Girne, Cyprus (Kktc), 17 - 21 September 2021, (Full Text)

23. Relationship between HS-CRP levels and prognosis in patient with pulmonary arterial hypertension.

Şahin A., Kaya H.

International Young Academy of Cardiology E-Congress, 18 September 2020, (Summary Text)

24. Left Atrial Diameter Is Associated With Stasis Dermatitis In Decompansated Heart Failure Patients.

KAYA Ö., ŞAHİN A., KAYA H.

International young academy of cardiology congress, 18 - 22 September 2019, (Full Text)

25. Stasis dermatitis is associated with prolonged length of stay for heart failure hospitalization

KAYA Ö., ŞAHİN A., KAYA H.

35. Uluslararası Kardiyoloji Kongresi, 3 - 06 October 2019, (Full Text)

26. Parathormone levels in patients with slow coronary flow

KURT R., KÜÇÜK U., ŞAHİN A., Ersoy B.

35. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, 03 October 2019

27. Meanplatelet volume as a predictor of heart failure related hospitalizations in stable heartfailure outpatients with sinus rhythm

KAYA H., ŞAHİN A., BETON O., YILMAZ M. B.

32. Turkish cardiology congress withinternational participations, 20 - 23 October 2016, (Summary Text)

Books 6

Publications & Works